Showing results (41-50 of 90) with videos related to
Sort By:
Pageof 9
Journal of Affective Disorders|January 8, 2021
A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusionsNelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.Expert Opinion on Drug Safety|June 17, 2020
Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellenceNelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.Acta Neuropsychiatrica|February 14, 2025
Association of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and neurogenesis: a systematic reviewHezekiah C T Au, Yang Jing Zheng, Gia Han Le, et al.Advances in Therapy|April 30, 2021
Strategies to Prolong Ketamine's Efficacy in Adults with Treatment-Resistant DepressionEric P McMullen, Yena Lee, Orly Lipsitz, et al.Journal of Affective Disorders|September 20, 2024
Association between rumination, suicidal ideation and suicide attempts in persons with depressive and other mood disorders and healthy controls: A systematic review and meta-analysisGia Han Le, Sabrina Wong, Hezekiah Au, et al.Journal of Psychiatric Research|March 11, 2021
The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic reviewJoshua D Di Vincenzo, Ashley Siegel, Orly Lipsitz, et al.Journal of Psychiatric Research|February 4, 2021
Ecological momentary assessment of depressive symptoms using the mind.me application: Convergence with the Patient Health Questionnaire-9 (PHQ-9)Roger S McIntyre, Yena Lee, Carola Rong, et al.Journal of Affective Disorders|September 3, 2020
Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of ExcellenceNelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.Expert Review of Neurotherapeutics|September 21, 2020
The emerging role of psilocybin and MDMA in the treatment of mental illnessHartej Gill, Barjot Gill, David Chen-Li, et al.European Archives of Psychiatry and Clinical Neuroscience|August 27, 2024
Subjective and objective measures of cognitive function are correlated in persons with Post-COVID-19 Condition: a secondary analysis of a Randomized Controlled TrialAngela T H Kwan, Moiz Lakhani, Gia Han Le, et al.Pageof 9